Namenda (Memantine HCL) Drug Information: Uses, Side Effects, Drug ...
Learn about the prescription medication Namenda (Memantine HCL), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
Memantine: Information from Answers.com
Memantine Memantine is a new drug for treating Alzheimer's disease, mental confusion, forgetfulness, ... Memantine: a review of its use in Alzheimer's disease" ...
Memantine - Wikipedia, the free encyclopedia
... neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease" ... Memantine: a review of its use in Alzheimer's disease" ...
Memantine
Excretion in breast milk unknown/use caution. Contraindications: ... following ingestion of memantine 400 mg. In case of overdose, treatment should ...
Memantine - Yahoo! Health
Before using memantine, tell your doctor if you are allergic to any drugs, or if ... Memantine reduces the actions of chemicals in the brain that may contribute to ...
memantine.com - Use of memantine in progressive glaucoma. Case report
Use of memantine in progressive glaucoma. Case report. Schroder A, Erb C. (2002) ... we investigated the use and tolerability of memantine in a glaucoma patient. ...
Memantine (Oral Route) - MayoClinic.com
Mayo Clinic offers award-winning medical and health information and ... information comparing the use of memantine in children with use in other age groups. ...
Memantine Advancing Toward Approval in U.S.
Memantine Officially Approved for Use in U.S.. by Richard O'Boyle, Publisher. More About Rich... One of the things that makes memantine so promising is ...
Memantine - Pubdrug
... schizophrenia and the use of memantine. Ann Pharmacother 2006;40 ... Memantine: a review of its use in Alzheimer's disease. Drugs. 2006;66(11):1515-34. ...
memantine - [Medication]
Before taking memantine, tell your doctor if you are using any of the ... Your use of the content provided in this service indicates that you have read, ...
|
Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease
[ Papers |
Articles |
Software |
Books |
Chapters |
Authors |
Institutions |
JEL Classification |
NEP reports |
Search |
New papers by email |
Author registration |
Rankings |
Volunteers |
FAQ |
Blog |
Help! ]
Memantine (Ebixa(R), Namenda(TM), Axura(R)) is an uncompetitive NMDA receptor antagonist used in the management of patients with moderate-to-severe Alzheimer's disease. It is currently the only drug approved for use in these more advanced stages of the disease. Significant reductions in functional and cognitive decline have been demonstrated with memantine relative to placebo in randomised, double-blind trials in this patient population. Clinical trial and postmarketing surveillance data indicate that the drug is generally well tolerated.